You can buy or sell BCYC and other stocks, options, and ETFs commission-free!
Bicycle Therapeutics plc American Depositary Shares, also called Bicycle Therapeutics, is a holding company, which engages in the development of biopharmaceuticals. It focuses on developing a novel class of medicines, which the company refers to as bicycles, for diseases that are underserved by existing therapeutics. The firm utilizes its novel and proprietary phage display screening platform to identify bicycles. Its portfolio includes internal product candidates that are directed to oncology applications. The company was founded by Gregory Winter, John Tite, and Christian Heinis in 2009 and is headquartered in Cambridge, the United Kingdom. The listed name for BCYC is Bicycle Therapeutics plc American Depositary Shares.
52 Week High
52 Week Low
— per share
Expected Mar 9, Pre-Market